Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-127730
Filing Date
2022-04-28
Accepted
2022-04-28 16:36:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d107411ddefa14a.htm DEFA14A 11714
2 GRAPHIC g107411g15m60.jpg GRAPHIC 97434
3 GRAPHIC g107411g32v68.jpg GRAPHIC 278186
  Complete submission text file 0001193125-22-127730.txt   530158
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40881 | Film No.: 22867303
SIC: 2834 Pharmaceutical Preparations